Market Overview

Rhythm Pharma (NASDAQ: RYTM)

24.16 +0.96 (4.14%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/03/20Morgan StanleyMaintainsOverweight30.0
10/27/20Canaccord GenuityMaintainsBuy37.0
10/26/20StifelMaintainsBuy36.0
4/15/20Morgan StanleyMaintainsOverweight31.0
1/08/20Goldman SachsInitiates Coverage OnSell18.0
11/11/19Morgan StanleyMaintainsOverweight34.0
7/12/19Stifel NicolausUpgradesBuy34.0
9/14/18Stifel NicolausInitiates Coverage OnHold36.0
9/07/18Morgan StanleyReinstatesOverweight38.0
10/30/17Bank of AmericaInitiates Coverage OnBuy30.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter